SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors
11 references·7 citing·34 second hop
Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors (2013)Prospective multicentre study of the effe…Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations (2010)Specific protein content of p…Adverse reactions to blood donations: the READ project. (2010)Adverse reactions to blood do…Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. (2009)Adverse reactions in blood an…A prospective multicentre study on the safety of long‐term intensive plasmapheresis in donors (SIPLA) (2006)A prospective multicentre stu…A prospective trial on the safety of long‐term intensive plasmapheresis in donors (2005)A prospective trial on the sa…The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers (2004)The impact of different inten…Plasma for fractionation: safety and quality issues (2004)Plasma for fractionation: saf…Determination of reasons for cessation of participation in serial plasmapheresis programs (1999)Determination of reasons for …Plasma proteins and lymphocyte phenotypes in long‐term plasma donors (1994)Plasma proteins and lymphocyt…Safety and Long‐term Effects of Plasmapheresis (1970)Safety and Long‐term Effects …Use of Plasmapheresis in Blood Donors (1952)Use of Plasmapheresis in Bloo…The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial (2024)The effect of donation freque…Balancing Donor Health and Plasma Collection: A Systematic Review of the Impact of Plasmapheresis Frequency (2024)Balancing Donor Health and Pl…Why do US source plasma donors stop donating? (2023)Why do US source plasma donor…Safety and protection of plasma donors: A scoping review and evidence gap map (2023)Safety and protection of plas…Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial (2023)Effects of plasmapheresis fre…A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis (2023)A donor safety evidence liter…The effect of plasmapheresis on blood pressure in voluntary plasma donors (2014)The effect of plasmapheresis …Severe outcomes of allogeneic and autologous blood donation: frequency and characterization (1995)A case‐controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse (1999)Faint and prefaint reactions in whole‐blood donors: an analysis of predonation measurements and their predictive value (2008)Adverse reactions in whole blood donors: an Indian scenario. (2011)Vasovagal reactions in whole blood donors at three REDS‐II blood centers in Brazil (2011)Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India (2013)Paying for blood donations: still a risk? (2002)International challenges of self-sufficiency in blood products (2013)Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand (2020)Shortage of plasma-derived products: a looming crisis? (2022)Frequency of immediate adverse effects associated with apheresis donation (1998)Blood donor complications after whole-blood donation (2004)Motivational differences between whole blood and plasma donors already exist before their first donation experience (2012)Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID ‐19 pandemic (2020)Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience (2008)Economical impact of plasma fractionation project in Iran on affordability of plasma‐derived medicines (2009)The Evolution of the Safety of Plasma Products from Pathogen Transmission—A Continuing Narrative (2023)Effects of Intensive Plasmapheresis on Normal Blood Donors (1964)Protein levels and plasmapheresis intensity (1993)Long‐term Plasmapheresis: Effects on Specific Plasma Proteins (1972)Short‐Term and Long‐Term Effects of Plasmapheresis on Serum Proteins and Immunoglobulins (1975)Plasmapheresis: recruitment, retention and flexible donors (2015)Review and assessment of the donor safety among plasma donors (2023)The safety of weekly plateletpheresis: effect on the donors' lymphocyte population (1981)Clinical Evaluation of Repeat Apheresis Donors in Japan (1999)The Interlinkage between Blood Plasma Donation and Poverty in the United States (2021)Plasmapheresis as a Form of Blood Donation (1964)The History and Development of the Plasma Protein Fractionation Industry (2012)Double Dose Plateletpheresis: A Savior to Shrinking Donor Pool and Platelet Inventory Management (2018)Apheresis affects bone and mineral metabolism (2009)Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium (2023)Immunoglobulin G levels during collection of large volume plasma for fractionation (2017)
this work references cited by second hop

References

  • 2010Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations76 cited
  • 2006A prospective multicentre study on the safety of long‐term intensive plasmapheresis in donors (SIPLA)76 cited
  • 2009Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.69 cited
  • 2004The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers53 cited
  • 1970Safety and Long‐term Effects of Plasmapheresis47 cited
  • 2004Plasma for fractionation: safety and quality issues42 cited
  • 2005A prospective trial on the safety of long‐term intensive plasmapheresis in donors37 cited
  • 1952Use of Plasmapheresis in Blood Donors33 cited
  • 1994Plasma proteins and lymphocyte phenotypes in long‐term plasma donors25 cited
  • 1999Determination of reasons for cessation of participation in serial plasmapheresis programs22 cited
  • 2010Adverse reactions to blood donations: the READ project.21 cited

Cited by

  • 2023Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial16 cited
  • 2023Safety and protection of plasma donors: A scoping review and evidence gap map14 cited
  • 2023

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis
13 cited
  • 2014The effect of plasmapheresis on blood pressure in voluntary plasma donors12 cited
  • 2024The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial10 cited
  • 2023Why do US source plasma donors stop donating?9 cited
  • 2024Balancing Donor Health and Plasma Collection: A Systematic Review of the Impact of Plasmapheresis Frequency8 cited